PYROTINIB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 70 adverse event reports in the FDA FAERS database where PYROTINIB was used for Breast cancer.
Most Reported Side Effects for PYROTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 62 | 25.3% | 2 | 35 |
| Diarrhoea | 57 | 23.3% | 6 | 10 |
| Vomiting | 39 | 15.9% | 3 | 7 |
| Nausea | 35 | 14.3% | 4 | 4 |
| Alanine aminotransferase increased | 32 | 13.1% | 3 | 14 |
| Anaemia | 28 | 11.4% | 3 | 1 |
| Palmar-plantar erythrodysaesthesia syndrome | 28 | 11.4% | 2 | 1 |
| Aspartate aminotransferase increased | 26 | 10.6% | 3 | 8 |
| Hypokalaemia | 25 | 10.2% | 3 | 9 |
| White blood cell count decreased | 25 | 10.2% | 4 | 10 |
| Fatigue | 22 | 9.0% | 3 | 0 |
| Disease progression | 21 | 8.6% | 0 | 4 |
| Thrombocytopenia | 21 | 8.6% | 0 | 1 |
| Decreased appetite | 20 | 8.2% | 6 | 1 |
| Neutropenia | 20 | 8.2% | 0 | 0 |
Other Indications for PYROTINIB
Breast cancer metastatic (52)
Her2 positive breast cancer (44)
Invasive ductal breast carcinoma (19)
Invasive breast carcinoma (8)
Metastases to central nervous system (7)
Chemotherapy (5)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)